Literature DB >> 27291979

Does ivabradine balance dobutamine effects in cardiogenic shock? A promising new strategy.

M Akodad1,2, P Lim3, F Roubille4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27291979     DOI： 10.1111/apha.12733

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN： 1748-1708            Impact factor:   6.311


× No keyword cloud information.
  3 in total

1.  Ivabradine in acute heart failure: Effects on heart rate and hemodynamic parameters in a randomized and controlled swine trial.

Authors:  Marina Pascual Izco; Rafael Ramírez-Carracedo; Ignacio Hernández Navarro; Álvaro Osorio Ruiz; Borja Castejón Navarro; Irene Cuadrado Berrocal; Carlota Largo Aramburu; Gonzalo Luis Alonso Salinas; Javier Díez; Marta Saura Redondo; José Luis Zamorano; Carlos Zaragoza; Marcelo Sanmartín
Journal:  Cardiol J       Date:  2018-08-29       Impact factor: 2.737

2.  Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial.

Authors:  Lee S Nguyen; Pierre Squara; Julien Amour; Daniel Carbognani; Kamel Bouabdallah; Stéphane Thierry; Caroline Apert-Verneuil; Aurélie Moyne; Bernard Cholley
Journal:  Crit Care       Date:  2018-08-17       Impact factor: 9.097

3.  Ivabradine-Stimulated Microvesicle Release Induces Cardiac Protection against Acute Myocardial Infarction.

Authors:  Rafael Ramirez-Carracedo; Laura Tesoro; Ignacio Hernandez; Javier Diez-Mata; Laura Botana; Marta Saura; Marcelo Sanmartin; Jose Luis Zamorano; Carlos Zaragoza
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.